Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ynot who wrote (58209)	8/28/1999 12:51:00 AM
From: red_dog	Read Replies (1) of 120523

Someone told me you were over playing the Hong markets with Jim Rogers, any truth to that. <g> Here is one that may look interesting. medscape.com New Cancer Drug Could Propel Coulter Into Biotech's Big League 08/27/1999 -------------------------------------------------------------------------------- NEW YORK -(Dow Jones)- Investors looking for market advice have been well-served by listening to Prudential Securities' Ralph Acampora over the past year. He became a household name last August after he accurately predicted a 15% to 20% correction in the stock market. Soon afterward, he returned to his bullish ways, encouraging his clients to buy back into the market. Once again, he was right. Occasional hiccups and bumps aside, the Dow Jones Industrial Average continues to forge ahead, regularly breaking records. We wondered if Acampora is as good at picking individual stocks as he is at calling the market as a whole. So we clicked onto his Web site and found that he has pounding the table for a handful of pharmaceutical companies that have recently had a little momentum in their sails. The word momentum is a clue: Acampora doesn't base his picks on a company's fundamentals; he's a technical analyst who studies charts looking for trends. That's usually a trader's game, but since Acampora is often on to something, we decided to sift through his list of names and apply some good old-fashioned analysis to find a compelling stock. Here's what we came up with: a small biotechnology company named Coulter Pharmaceutical Inc. (CLTR). Coulter, based in South San Francisco, develops cancer Rg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next